Co-Diagnostics, Inc. (CODX): Cash & Equivalents
$11.88M
As of 2025-12-31
$3.65M
As of 2026-06-30
-19.7%
3-year compound annual growth
-22.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.88M | +304.7% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.94M | -80.3% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $14.92M | -35.1% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $22.97M | -74.1% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $88.61M | +106.2% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $42.98M | n/m | 2022-03-24, Balance as of period end |
| 2019-12-31 | $893.1K | -6.0% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $950.2K | -73.1% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $3.53M | +253.9% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $998.7K | n/a | 2018-03-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $11.88M | +304.7% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $1.35M | -45.6% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $88.0K | -96.9% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.14M | +15.1% |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $80.73M | -31.6% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $7.02M | -1.8% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $3.16M | -38.2% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $5.79M | -16.2% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $87.0K | -17.7% |
Compare CODX, HRGN, VTAK, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗